Figures & data
Figure 1. TKTL1 immunohistochemical staining of colorectal cancer samples. Samples were scored for cytoplasmic intensity by a 4-grade scale as follows, (A) negative (B) mild (C) intermediate (D) strong. Original magnification was 400X.
![Figure 1. TKTL1 immunohistochemical staining of colorectal cancer samples. Samples were scored for cytoplasmic intensity by a 4-grade scale as follows, (A) negative (B) mild (C) intermediate (D) strong. Original magnification was 400X.](/cms/asset/b60185b3-21a4-4f66-80ec-50cfda6ccff6/kcbt_a_1121347_f0001_c.gif)
Table 1. Association of TKTL1 with clinicopathologic variables in 733 colorectal cancer patients.
Table 2. Kaplan-Meier analysis for disease-specific survival stratified for subgroups of colorectal cancer patients (P-value for logrank test).
Figure 2. Disease-specific survival according to TKTL1 expression in colorectal cancer patients. Prognosis was better in those with low expression of TKTL1, and worse in those with high expression of TKTL1 (p = 0 .024)
![Figure 2. Disease-specific survival according to TKTL1 expression in colorectal cancer patients. Prognosis was better in those with low expression of TKTL1, and worse in those with high expression of TKTL1 (p = 0 .024)](/cms/asset/4bb11093-4553-4593-81d4-b4d6a443aef2/kcbt_a_1121347_f0002_b.gif)
Table 3. Cox regression analysis for disease-specific survival of colorectal cancer patients.